CDC 70i
Isopropyl Alcohol
Search
15 matching records for CDC.
NDC#
DailyMed#
Premier Value (CDC) Multi-Symptom Nighttime Cold/Flu Relief Drug Facts
20200305
Premier Value (CDC) Cold & Flu Relief Drug Facts
20200305
CDC 70i
2022-01-14
CDC 70i
2022-01-14
CDC 75i
2022-01-14
CDC 70i
2022-01-14
GMDN Terms#
HLA class I antigen tissue typing IVD, kit, complement-dependent cytotoxicity (CDC)
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of one or multiple HLA class I antigens in a clinical specimen, using a complement-dependent cytotoxicity (CDC) method.
HLA class I antibody identification panel IVD, kit, complement-dependent cytotoxicity (CDC)
A collection of reagents and other associated materials intended to be used for the identification in a clinical specimen of one or multiple antibodies to HLA class I antigens, using lymphocyte antigens together with a complement-dependent cytotoxicity (CDC...
HLA class II antibody identification panel IVD, kit, complement-dependent cytotoxicity (CDC)
A collection of reagents and other associated materials intended to be used for the identification of one or multiple antibodies to HLA class II antigens in a clinical specimen, using lymphocyte antigens together with a complement-dependent cytotoxicity (CD...
HLA class II antigen tissue typing IVD, kit, complement-dependent cytotoxicity (CDC)
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of one or multiple HLA class II antigens in a clinical specimen, using a complement-dependent cytotoxicity (CDC) method.
Complement reagent IVD
A solution containing complement proteins intended to be used alone or in combination with other IVDs in the processing, staining and/or testing of clinical laboratory specimens. Typical uses may include HLA tissue typing by a complement-dependent cytotoxic...
HLA class II tissue typing IVD, antibody
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used in testing for one or multiple HLA class II antigens (i.e., HLA-D) in a clinical specimen, using techniques which may include complement-dependent ...